Recall all batches of SENSITYN 1000/50mg and SENSITYN 850/50mg
2026-02-26Product Description :
|
الاسم التجاري |
الاسم العلمي |
رقم التسجيل |
رقم التشغيلة المتأثرة |
الشركة الصانعة |
|
Trade Name |
Scientific Name |
Register Number |
Affected batch number |
Manufacturer |
|
SENSITYN1000/50mg |
METFORMINHYDROCHLORIDE1000MG,VILDAGLIPTIN50MG |
1107233858 |
جميع التشغيلات |
Alpha pharma industry |
|
SENSITYN 850/50mg |
METFORMINHYDROCHLORIDE850MG,VILDAGLIPTIN50MG |
1107233857 |
جميع التشغيلات |
Alpha pharma industry |
Issue :
SFDA has issued a recall of all batches of SENSITYN 1000/50mg and SENSITYN 850/50mg due to decision of the Committee for the Registration of Pharmaceutical Companies, Manufacturers, and Their Products No. 47/1257/SFDA/121
Recommendations :
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).